Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CLVT | Ordinary Shares | Award | $0 | +11.2K | +363.62% | $0.00 | 14.2K | May 5, 2022 | Direct | F1 |
transaction | CLVT | Ordinary Shares | Tax liability | -$9.01K | -615 | -4.32% | $14.65 | 13.6K | May 6, 2022 | Direct | F2 |
holding | CLVT | Ordinary Shares | 12.3M | May 5, 2022 | See Footnote | F3 |
Id | Content |
---|---|
F1 | Reflects the grant of an annual non-employee director award of restricted share units granted pursuant to the Clarivate Plc 2019 Incentive Award Plan, which will vest on May 5, 2023. |
F2 | Reflects shares withheld to satisfy taxes. |
F3 | Includes (i) 2,145,316 ordinary shares of Clarivate held directly by A-PQ Holdings and (ii) 10,114,531 ordinary shares of Clarivate indirectly held by A-PQ Holdings through ProQuest Holdings LLC. Mr. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P., which is the sole voting shareholder of Atairos Group, Inc. Atairos Group, Inc. is the sole member of A-PQ Holdings. Mr. Angelakis disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |